Blog: CABALETTA BIO, INC. : Regulation FD Disclosure, Other Events, Financial Statements and Exhibits (form 8-K) –

Item 7.01 Regulation FD Disclosure.

On September 10, 2022, Cabaletta Bio, Inc. (the “Company”) posted to the
“Investors & Media” section of the Company’s website at an
updated corporate presentation providing a corporate overview and updated
development plan (the “Corporate Presentation”). A copy of the Corporate
Presentation is attached hereto as Exhibit 99.1 and is incorporated by reference
into this Item 7.01 of this Current Report on Form 8-K.

The information contained in Item 7.01 of this Current Report on Form 8-K is
being furnished and shall not be deemed to be “filed” for the purposes of
Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange
Act”), or otherwise subject to the liabilities of that section and shall not be
incorporated by reference in any filing under the Securities Act of 1933, as
amended, or the Exchange Act, except as shall be expressly set forth by specific
reference in such filing.

Item 8.01 Other Events.

On September 10, 2022, the Company issued a press release announcing that it
presented updated clinical and translational data through 6 months of follow-up
in cohorts A1 through A4 as well as 28-day safety data and DSG3-CAART
persistence data through day 29 for cohorts A1 through A5 from the DesCAARTes™
trial at the 31st European Academy of Dermatology and Venereology (EADV)
Congress. A copy of the full text of the press release referenced above is filed
as Exhibit 99.2 to this Current Report on Form 8-K and is incorporated herein by
reference into this Item 8.01 of this Current Report on Form 8-K.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

99.1      Cabaletta Bio, Inc. Corporate Presentation, dated September 10, 2022,
        furnished herewith.

99.2      Press Release issued by the registrant on September 10, 2022.

104     Cover Page Interactive Data File (embedded within the Inline XBRL


© Edgar Online, source Glimpses

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s